NEWS

Y-Stent-assisted coiling for Left MCA bifurcation aneurysm

The evolution and future of Surgical Robotics

Galaxy Therapeutics Achieves CE Mark for SEAL™ Embolization System, Enab...

Galaxy Therapeutics, a privately held medical device company dedicated to advancing the treatment of intracranial aneurysms, today announced that it has received CE Mark under the European Medical Device Regulation (EU MDR 2017/745) for the SEAL™ Embolization System, following successful assessment by Notified Body DQS Medizinprodukte GmbH.

Acandis Receives Regulatory Approval to Launch SONIC Pivotal Clinical In...

Acandis GmbH, a leading Germany medical technology company specialising in devices for neurovascular interventions, announced today that it has received approval from the German Federal Institute for Drugs and Medical Devices (BfArM) to initiate the SONIC clinical investigation in Germany.

“Slow-deconstructive” approach in a patient with acute stroke and fusiform MCA aneurysm

Jacques Moret, inside the mind of a pioneer

Large paraclinoid aneurysm treated with flow diversion with OCT control

Vesalio Appoints Greg Cook as Chief Commercial Officer

Greg Cook joins Vesalio as Chief Commercial Officer to lead commercial strategy and execution across its thrombectomy platform. Dallas, Texas – July 14, 2026

Transforming neurovascular care with simulation software

COATING trial: 1-year results on HPC coating | LINNC online